María Teresa Illnait Zaragozí

Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole

Ana Espinel‐Ingroff, Ana Isabel Aller, Laura Rosío Castañón-Olivares et al. · Antimicrobial Agents and Chemotherapy · 2012 · 247 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +14

Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the <i>Cryptococcus</i> Genus

Ferry Hagen, H. Thorsten Lumbsch, Valentina Arsić‐Arsenijević et al. · mSphere · 2017 · 143 citations · Full text

Life Sciences, Biology, Microbiology +11

<i>In Vitro</i> Antifungal Susceptibilities and Amplified Fragment Length Polymorphism Genotyping of a Worldwide Collection of 350 Clinical, Veterinary, and Environmental <i>Cryptococcus gattii</i> Isolates

Ferry Hagen, María Teresa Illnait Zaragozí, Karen H. Bartlett et al. · Antimicrobial Agents and Chemotherapy · 2010 · 123 citations

Life Sciences, Microbiology, Veterinary Microbiology +15

Tracing Genetic Exchange and Biogeography of <i>Cryptococcus neoformans</i> var. <i>grubii</i> at the Global Population Level

Johanna Rhodes, Christopher A. Desjardins, Sean M. Sykes et al. · Genetics · 2017 · 107 citations · Full text

Life Sciences, Genetics, Microbiology +17

<i>In Vitro</i> Activities of Eight Antifungal Drugs against 55 Clinical Isolates of <i>Fonsecaea</i> spp

Mohammad Javad Najafzadeh, Hamid Badali, María Teresa Illnait Zaragozí et al. · Antimicrobial Agents and Chemotherapy · 2010 · 69 citations · Full text

Medicine, Microbiology, Pharmacology +8